After only one month, our Biotech insider, David Zickafoose, has reached an impressive 19% return on his idiosyncratic biotech picks.
That is by any measure a very impressive start to his portfolio. We look forward to see the portfolio´s performance this year out.
To share the wealth we have an offer for our long time visitor – first time subscriber.
You can get access to all our independent fundmanagers for just $20 dollars the first month (a 33% discount).